Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for Celltech
Birss J excuses Chugai from tocilizumab royalties in UCB "validity tie breaker" Birss J excuses Chugai from tocilizumab royalties in UCB "validity tie breaker" Reviewed by Annsley Merelle Ward on Friday, August 24, 2018 Rating: 5
A Tight Squeeze: Matters of Comity and Justiciability A Tight Squeeze: Matters of Comity and Justiciability Reviewed by Stephen on Friday, June 09, 2017 Rating: 5
Celltech flexes its muscle against OHIM Celltech flexes its muscle against OHIM Reviewed by Jeremy on Thursday, April 19, 2007 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.